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Abstract

In an effort to understand the reaction mechanism of a B2 metallo-β-lactamase, steady-state and pre-steadystate kinetic and rapid freeze quench electron paramagnetic resonance (EPR) studies were conducted on ImiS
and its reaction with imipenem and meropenem. pH dependence studies revealed no inflection points in the pH
range of 5.0−8.5, while proton inventories demonstrated at least 1 rate-limiting proton transfer. Site-directed
mutagenesis studies revealed that Lys224 plays a catalytic role in ImiS, while the side chain of Asn233 does not
play a role in binding or catalysis. Stopped-flow fluorescence studies on ImiS, which monitor changes in
tryptophan fluorescence on the enzyme, and its reaction with imipenem and meropenem revealed biphasic
fluorescence time courses with a rate of fluorescence loss of 160 s-1 and a slower rate of fluorescence regain of
98 s-1. Stopped-flow UV−vis studies, which monitor the concentration of substrate, revealed a rapid loss in
absorbance during catalysis with a rate of 97 s-1. These results suggest that the rate-limiting step in the reaction
catalyzed by ImiS is C−N bond cleavage. Rapid freeze quench EPR studies on CoII-substituted ImiS demonstrated
the appearance of a rhombic signal after 10 ms that is assigned to a reaction intermediate that has a fivecoordinate metal center. A distinct product (EP) complex was also observed and began to appear in 18−19 ms.
When these results are taken together, they allow for a reaction mechanism to be offered for the B2 metallo-βlactamases and demonstrate that the mono- and dinuclear ZnII-containing enzymes share a common ratelimiting step, which is C−N bond cleavage.

Bacterial resistance to antibiotics is a growing clinical concern (1, 2). ZnII-containing β-lactamases (metallo-βlactamases, MβLs)1 contain 1−2 mol of ZnII/mol of enzyme, hydrolyze all known cephalosporins, carbapenems,
and penicillins, are not inhibited by clavulanic acid and other classical β-lactamase inhibitors, and have no known
clinically useful inhibitor toward them (3, 4). Previous studies have shown that there is significant structural and
mechanistic diversity among the MβLs, leading to the grouping of the enzymes into three distinct subclasses:
B1, B2, and B3 (5, 6). Sequence identity ranges from 25−40% between members in one subclass and from
10−20% between members in different subclasses. Subclass B1 enzymes have been found in strains
of Bacillus, Bacteroides, Pseudomonas, Serratia, and Chryseobacterium, and subclass B3 enzymes have been
found in strains of Stenotrophomonas, Legionella, Fluoribacter, Janthinobacterium, and Caulobacter (3, 4).
Enzymes from the B1 and B3 subclasses have broad substrate profiles and require two ZnII ions for maximal
enzymatic activity (3). In contrast, subclass B2 enzymes have a relatively narrow substrate profile, hydrolyzing

carbapenems almost exclusively (3), and exhibit maximal activity when bound to only 1 ZnII (7). In fact, the
binding of a second ZnII ion is inhibitory (7). These carbapenemases are produced by various species
of Aeromonas. Aeromonads are enteric, anaerobic, Gram-negative pathogens that cause a range of symptoms
from mild diarrhea to acute gastroenteritis in humans (8), and Aeromonas species have been found in wound
infections (9). One alarming characteristic of Aeromonads is that they are waterborne and typically are present
in purified, drinking water (10). To date, there is no crystal structure available for ImiS, but the crystal structure
of another subclass B2 enzyme, CphA from Aeromonas hydrophila, has been recently reported (11). This
structure showed ZnII bound to His263, Cys221, Asp120, and a water; this site is the consensus Zn2 site in MβLs
(3). Recent spectroscopic studies have demonstrated that ZnII/CoII preferentially binds to this same site in ImiS
(12). Previous biochemical, kinetic, and inhibition studies have suggested significant structural and mechanistic
differences among the different group B β-lactamases (3, 4, 13). These results suggest that one inhibitor may not
be effective in treating all infections caused by bacteria that produce a MβL. Toney and Moloughney recently
reviewed the literature on inhibitors of MβLs (13), and most of these inhibitors are effective against only one or
two of the enzymes. This is not surprising because, with few exceptions (14−16), the design of most of the
inhibitors was guided by studies on only one enzyme. To address this problem, we are currently characterizing a
MβL from each of the group B subclasses (CcrA, ImiS, and L1) in an effort to identify common
structural/mechanistic properties of the enzymes toward which a single inhibitor can be designed. While
extensive mechanistic studies have been reported on B1 and B3 MβLs (17−24), there is little known about the
mechanism of a B2 MβL. Herein, we describe the first detailed mechanistic studies on a B2 MβL, specifically ImiS
from Aeromonas veronii bv. sobria.

Experimental Procedures
Preparation of ImiS Samples.
Recombinant ImiS was prepared as described previously (25). Briefly, the overexpression plasmid, pET26b-ImiS,
was used to transform BL21(DE3) Escherichia coli cells. A 10 mL overnight culture of these cells in Luria−Bertani
(LB) medium was used to innoculate 4 × 1 L of LB medium containing 25 μg/mL kanamycin and 29 μg/mL
ZnSO4·7H2O. The cells were allowed to grow at 37 °C with shaking until the cells reached an optical density at
600 nm of 0.6−0.8. Protein production was induced with 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG), and
the cells were shaken at 37 °C for 3 h. The cells were collected by centrifugation (15 min at 7000g) and
resuspended in 30 mL of 50 mM tris(hydroxymethyl)aminomethane (Tris) at pH 7.0 containing 500 mM NaCl.
The cells were ruptured by two passages through a French press at 16 000 lb/in., and the cell debris was
separated by centrifugation (30 min at 25000g). The cleared supernatant was dialyzed versus 2 L of 50 mM Tris
at pH 7.0 overnight at 4 °C, centrifuged to remove insoluble matter, and loaded onto a SP-Sepharose column
(1.5 × 12 cm with a 25 mL bed volume) that was equilibrated with 50 mM Tris at pH 7.0. Bound proteins were
eluted with a 0−500 mM NaCl gradient in 50 mM Tris at pH 7.0 and 2 mL/min. Fractions (8 mL) containing ImiS
were pooled and concentrated with an Amicon ultrafiltration cell equipped with a YM-10 membrane. Protein
purity was ascertained by sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE). ImiS
concentrations were determined using Beer's law and an extinction coefficient of 37 250 M-1 cm-1 (25). CoIIsubstituted ImiS was prepared as previously described (12).

Substrate Inhibition Studies.
Substrate inhibition studies were carried out on recombinant ImiS using imipenem or meropenem as the
substrate. Assays were conducted at 25 °C in 50 mM Tris at pH 7.0 on an HP 5480A diode array UV−vis
spectrophotometer. Initial velocity versus imipenem concentration data were plotted and fitted with
Michaelis−Menten equations assuming different modes of substrate inhibition (26). Imipenem and meropenem
were gifts from Merck and Co. (Rahway, NJ) and Zeneca Pharmaceuticals (Wilmington, DE), respectively.

Product Studies.
Hydrolyzed products of imipenem were prepared by incubating 8 mM imipenem in 50 mM Tris at pH 7.0 with
either 190 μM ImiS or 100 μM L1 (27), and the reactions were incubated on ice for 2 h. The enzymes were
removed by using ultrafiltration (Centricon-10), and the resulting product containing solutions were analyzed at
280 and 300 nm using UV−vis spectrophotometry to determine whether the solutions contained any protein or
unhydrolyzed imipenem. The solutions were then flash-frozen in liquid nitrogen and lyophilized overnight. The
products were analyzed with 1H nuclear magnetic resonance (NMR) spectroscopy (Bruker 500 MHz) or by liquid
chromatography−mass spectrometry (LC−MS) (Bruker Esquire, ESI). The lyophilized products were then
dissolved in 50 mM Tris at pH 7.0 and used in product inhibition studies with L1 (nitrocefin as the substrate) and
ImiS (imipenem as the substrate).

pH Dependence Studies.
pH dependence studies were performed on recombinant ImiS over the pH range of 5.0−8.5 using a
multicomponent buffer, MTEN. MTEN (25 mM MES, 25 mM Tris, 25 mM ethanolamine, and 100 mM NaCl) was
used to minimize the effects of using different buffers over wide ranges of pH, and the NaCl was included to
normalize the ionic strength effects in the buffer (28). The pH of the buffers was ascertained by using a pHmeter. Steady-state kinetic assays were conducted at 25 °C in 50 mM Tris buffer at pH 7.0 on a HP 5480 diode
array UV−vis spectrophotometer. Steady-state kinetic constants, KM and kcat, were determined by fitting initial
velocity versus substrate concentration data directly to the Michaelis−Menten equation using Igor Pro version
4.0.5.1 (Wavemetrics). The pH dependence data were fitted with Leonara (29); however, no pKa values above
5.5 or below 8 were revealed with this software.

Proton Inventories.
Proton inventories were performed with ImiS in MTEN buffer at pH/pD 7.0 using imipenem as the substrate.
Enzyme and substrate were incubated in the D2O-containing buffer for 30 min to allow for full proton−deuteron
equilibration. Data were collected in buffers containing 0, 25, 50, 75, and 100% D2O [mole fraction of D2O (n) = 0,
0.25, 0.5, 0.75, and 1.0]. The steady-state kinetic constant, kcat, was obtained as described above. The resulting
kinetic constants were plotted versus their mole fraction D2O and fitted to the Gross−Butler equation for one
(kcat 0[1 − n + (n(kD/kH))], two (kcat 0[1 − n + (n(kD/kH)][1 − n + (n(kD/kH)], and multiple (kcat 0[(kD/kH)n]) protons in
flight models (30, 31).

Generation and Characterization of K224T and N233S Mutants.
Using the PAGE-purified oligonucleotides primers and the overexpression plasmid for ImiS (pET26b-ImiS) as the
template, ImiS mutants were generated using the Quikchange site-directed mutagenesis kit according to the
instructions of the manufacturer. The primers used for the mutagenesis studies were K224T forward,
CTTTATggCAACTgCATCCTCACCgAGAAGCTgggCAACCTgAgCTTTgCC; K224T reverse,
ggCAAAgCTCAggTTgCCCAgCTTCTCggTgAggATgCAgTTgCCATAAAg; N223S forward,
gCCTTCACATCggCAAAgCTCAggCTgCCCAgCTTCTCCTTgAggAT; N223S reverse,
ATCCTCAAggAgAAgCTgggCAgCCTgAgCTTTgCCgATgTgAAggC. DNA sequencing of the mutated imiS genes using T7
forward (TAATACgACTCACTATAgg) and T7 reverse ( CgATCAATAACGAgTCgCC) as the primers was used to
confirm the presence of the mutation and that no other unintended mutations were present in the genes. These
DNA sequences were analyzed on the Perkin-Elmer ABI 3100 genetic analyzer.
To test for the overexpression of mutants, the mutant plasmids were transformed into E. coli BL21(DE3) cells
and small-scale cell cultures were used (32). Large-scale 4 L preparations were performed using the protocol
described above for wild-type ImiS. ZnII-loaded samples of ImiS and ImiS mutants were made 100 μM in ZnII and
incubated for 30 min on ice. The samples were then dialyzed versus 3 × 1 L of metal-free, 50 mM Tris at pH 7.0

and 4 °C over a 6 h time period to remove any unbound ZnII. These ZnII-loaded samples of ImiS and ImiS mutants
were diluted to a final enzyme concentration of 5−10 μM. The metal content of these samples was determined
using a Varian Liberty 2 inductively coupled plasma spectrometer with atomic emission spectroscopy detection
(ICP−AES). The final dialysis buffer was used as a blank. Calibration curves for all metals tested were based on at
least three concentration replicates, and all calibration curves had correlation coefficients of 0.9950 or better.
Emission lines were monitored at 213.856, 238.892, 324.754, 259.940, 257.610, and 231.604 nm, with the most
intense emissions for zinc, cobalt, copper, iron, manganese, and nickel, respectively. Errors in metal content
were reported as standard deviations (σn-1) of replicate samples.
ZnII-loaded ImiS and ImiS mutants were dialyzed versus 3 × 2 L of 5 mM phosphate at pH 7.0 over 6 h. The
samples were then diluted with the same buffer to a final concentration of approximately 75 μg/mL. Circular
dichroism (CD) spectra were obtained on a JASCO J-810 CD spectropolarimeter, operating at 25 °C. CD spectra
were analyzed for secondary structural content using the CONTIN simulation program at DICHROWEB
(http://www.cryst.bbk.ac.uk/ cdweb/html/home.html) (33, 34).
ZnII-loaded ImiS and ImiS mutants were diluted with metal-free, 50 mM Tris at pH 7.0 to a final concentration of
2 μM. Fluorescence spectra were obtained at 25 °C using an excitation wavelength of 295 nm on a Perkin-Elmer
LS55 luminescence spectrophotometer.

Stopped-Flow Kinetic Studies.
Hydrolysis of imipenem (10−350 μM) by ImiS (120 μM) in 50 mM Tris buffer at pH 7.0 and 2 °C was followed by
electronic absorption at 300 nm and by 280 nm excited fluorescence emission at ≥320 nm (320 nm cutoff filter)
on an Applied Photophysics SX18MV spectrophotometer. Time-dependent electronic absorption spectra of CoIIsubstituted ImiS (500 μM) were collected using a photodiode array (PD.1, Applied Photophysics) upon the
recation with 500 μM imipenem at 2 °C. Kinetic data were fitted to either single- or double-exponential
equations using KinTekSim version 3.20 software (http://www.kintek-corp.com/). Stopped-flow fluorescence
data were also globally fitted using Applied Photophysics PC ProK global analysis software.

Kinetic Simulations.
Kinetic simulations were conducted using KINSIM (35). The values for flux and integral tolerances were left as
the default values of 0.02 and 1 × 10-6, respectively.

Rapid Freeze Quench (RFQ) Electron Paramagnetic Resonance (EPR) Spectra.
Samples for RFQ−EPR studies were generated using a modified Update Instruments (Madison, WI) RFQ system
(21). The RFQ system was calibrated by comparing the development of a low-spin FeIII EPR signal and the
disappearance of a high-spin FeIII EPR signal with the associated optical changes at 636 nm using stopped-flow
spectrophotometry, upon mixing myoglobin with an excess of sodium azide. The shortest, total effective
reaction time that could be achieved with the RFQ system was 10 ms. The initial concentrations of Co IIsubstituted ImiS and imipenem were 1 and 5 mM, respectively. EPR spectra were recorded using a Bruker
EleXsys E500 EPR spectrometer equipped with an Oxford Instruments ITC4 temperature controller and an ESR900 helium flow cryostat. Spectra were recorded at 12 K with 1 mW microwave power. A Bruker ER-4116DM
cavity was used, with a resonant frequency of 9.63 GHz (in perpendicular mode), and 10 G (1 mT) field
modulation at 100 kHz was employed. Computer simulations of EPR spectra were carried out using the matrix
diagonalization program XSophe [Bruker Biopsin GmbH] (36), assuming a spin Hamiltonian H = βgBS + SDS + SAI,
where S = 3/2 and D > 0 corresponds to an MS = |±1/2〉 ground-state Kramers' doublet. For CoII, generally D ≫
βgBS and the spectrum is therefore insensitive to the precise value of D (37); in this work, the arbitrary value D =
50 cm-1 was used. The g tensor was assumed to have at least axial symmetry because this allows for a unique
solution to the spin Hamiltonian in terms of the real g values, gz and gx,y (or g∥ and g⊥), and the rhombic

distortion of the axial zero-field splitting, E/D (37). The relationship between the resonance positions, geff(x,y,z),
and these parameters are described in detail elsewhere (38, 39). Line widths were simulated using a single-strain
parameter for each of the principal orientations. Where simulations of spectra are shown that contain more
than one species, spectra that could be well-simulated assuming a single set of spin Hamiltonian parameters
were used as basis spectra and linear combinations of two (and no more than two) basis spectra were used to
model the spectra collected after reaction times, intermediate between those after which the basis spectra
were recorded. Contributions of the individual species are estimated as ±5% of the total spins.

Results
Substrate Inhibition.
Many enzymes conform to Michaelis−Menten kinetics over a limited range of substrate concentrations but
deviate at higher substrate concentrations (40). Steady-state kinetic studies with ImiS and using imipenem or
meropenem resulted in Michaelis−Menten plots that indicate significant substrate inhibition (Figure 1). Several
substrate inhibition models [competitive, noncompetitive, etc. (26)] were tested to fit the observed steady-state
kinetic data, and a model defined by uncompetitive substrate inhibition was the model that best-fitted the data
(line in Figure 1).

Figure 1 Michaelis−Menten plot of imipenem hydrolysis by ImiS in 50 mM Tris at pH 7.0 and 25 °C. The data
were fitted to a Michaelis−Menten equation with uncompetitive substrate inhibition (26).

Product Inhibition Studies.
The recent crystal structure of CphA showed a unique bicyclic “intermediate” in the active site of the enzyme
that is formed by the attack of the invariant hydroxyl group of the 6‘ substituent of biapenem (and other
carbapenems) on the 3‘ carbon of the five-membered ring (11). Garau et al. argued that the formation of the
second ring in the product occurs after C−N bond cleavage (11). To ascertain whether this bicyclic, hydrolyzed
carbapenem is catalytically competent, we hydrolyzed imipenem with ImiS and with L1. L1 and ImiS were
removed from the solutions by ultrafiltration, and the products were analyzed with 1H NMR spectroscopy and
LC−MS. There were no differences in the mass spectra or the NMR spectra of the two products. Neither product
absorbed in the UV−vis region about 280 nm.
Therefore, the ImiS- and L1-generated products were used in product inhibition studies. The ImiS-generated
product inhibited ImiS with a Ki of 53 ± 5 μM and inhibited L1 with a Ki of 615 ± 50 μM. The L1-generated
product inhibited ImiS with a Ki of 4 ± 1 mM and inhibited L1 with a Ki of 2 ± 1 mM. Clearly, the ImiS-generated
product is distinct from the L1-generated product.

pH Dependence Studies.
pH dependence kinetic studies can be used to probe for groups with ionizable protons associated on the free
enzyme, free substrate, or enzyme−substrate complex (40). In pH dependence studies on ZnII-containing ImiS, a
relatively narrow pH range of 5.0−8.5 was used because ImiS precipitated at pH values below 5.0 and above 8.5.

A multicomponent buffer, MTEN (28), was used to minimize buffer and ionic strength effects. The log kcat and
log(kcat/KM) versus pH plots (Figure 2) for hydrolysis of imipenem by ZnII-containing ImiS were fitted with Leonara
(29); however, no pKa values above 5.5 or below 8.0 were revealed. Similar results have been reported for the
dinuclear ZnII-containing β-lactamases L1 and CcrA (18, 41). pH dependence plots for CoII-substituted ImiS with
imipenem also did not reveal any inflection points (data not shown).

Figure 2 pH dependence plots of log kcat (·) and log kcat/KM (▪) for the hydrolysis of imipenem by ImiS in MTEN
buffer. The data points represent average values from at least three trials. Error bars represent the standard
deviation of multiple trials.

Solvent Isotope Studies.
Solvent isotope studies have been extensively used in the literature to probe reaction mechanisms of enzymes,
specifically to identify any rate-limiting proton transfers (31). The hydrolysis of imipenem by ImiS yielded a
solvent isotope effect (kH/kD) of 1.7 ± 0.2, suggesting a proton transfer during a nucleophilic reaction. A proton
inventory of ImiS yielded a kcat versus mole fraction of D2O that was best-fitted to a multiple proton in flight
model (Figure 3); however, we cannot unambiguously rule out the one or two proton in flight models (30).
Similar proton inventories have been reported for dinuclear ZnII-containing L1 and CcrA (28, 41).

Figure 3 Proton inventory of imipenem hydrolysis by ImiS. Data points represent averages of at least three trials,
and error bars are standard deviations. The data were fitted to single proton (···), two proton ( ), and multiple
proton in flight (-·-) models (30).

K224T and N233S Mutants of ImiS.
A lysine is located at position 224 in all sequenced MβLs except in L1 from Stenotrophomonas maltophilia (6).
Lys224 has been proposed to be involved in substrate binding via electrostatic interactions with the invariant
carboxylate group of the β-lactam-containing antibiotics (11, 42, 43). To test this hypothesis, Lys224 was
mutated to a threonine using site-directed mutagenesis. Bordo and Argos have reported that threonine is the
“safest” substitution in mutagenesis studies for exposed lysines (44). Small-scale cultures were used to show
that the K224T mutant could be overexpressed and purified at levels comparable to wild-type ImiS. CD and

fluorescence spectra of the K224T mutant were similar to those of wild-type ImiS (data not shown), suggesting
that the point mutation does not result in large structural changes in the enzyme.
Metal analyses on as-isolated and ZnII-loaded K224T demonstrated that the mutant binds 0.80 and 0.78 equiv of
ZnII, respectively, which is similar to the metal content of wild-type ImiS (Table 1). Steady-state kinetics revealed
that this mutant exhibited a 16-fold drop in kcat and a 4-fold increase in KM when using imipenem as a substrate
(Table 1). In studies using meropenem as the substrate, the K224T mutant exhibited no change in KM and a 740fold decrease in kcat (Table 1).
Table 1: Steady-State Kinetic Constants and Metal Content of ImiS Mutantsa
imipenem kca imipenem Km meropenem kc meropenem Km ZnII equiv asZnII equiv ZnII-1
-1
(μM)
(μM)
isolated
loadedb
t (s )
at (s )
wild type 350 ± 15
100 ± 10
296 ± 20
308 ± 55
0.90 ± 0.06
0.85 ± 0.06
K224T
17 ± 3
208 ± 90
0.67 ± 0.07
136 ± 30
0.80 ± 0.07
0.78 ± 0.15
N233S
303 ± 27
109 ± 22
270 ± 28
151 ± 33
0.77 ± 0.08
0.90 ± 0.08
a
Steady-state kinetic constants and metal content were determined on at least three different preparations of
the enzymes. Steady-state kinetic studies were conducted in 50 mM Tris at pH 7.0 and 25 °C.b ZnII-loaded
samples were prepared by incubating the as-isolated enzymes with 100 μM ZnII for 30 min and dialyzed 3 times
versus 1 L of 50 mM Tris at pH 7.0 for 2 h each.
enzyme

An asparagine is located at position 233 in all MβLs except L1 from S. maltophilia (subclass B3) (45), BlaB
(subclass B1) (46), and IND-1 from Chryseobacterium species (subclass B1) (47). The N233S mutant could be
overexpressed and purified at levels comparable to that of wild-type ImiS. This mutant also exhibited CD and
fluorescence spectra similar to those of wild-type ImiS (25), suggesting that the point mutation did not cause a
change in the structure of the enzyme. Metal analyses revealed that as-isolated and ZnII- loaded N233S bound
0.77 and 0.99 equiv of ZnII, respectively (Table 1). Steady-state kinetics revealed that the N233S mutant
exhibited steady-state kinetic constants similar to those of wild-type ImiS (Table 1).

Stopped-Flow Kinetic Studies.
In initial stopped-flow UV−vis studies, we reacted CoII-substituted ImiS with imipenem and we monitored the
reaction using diode array detection, particularly in the 500−650 nm region of the spectra, in an effort to probe
the ligand field transitions of high-spin CoII during the course of the reaction. In all of the experiments that we
conducted, there were no observable changes in the intensities of the ligand field bands. Therefore, we chose to
monitor the change in absorbance of the substrate during the course of the reaction. The rate of imipenem
hydrolysis, monitored by stopped-flow spectrophotometry (Figure 4), was a complex function of the
concentration of imipenem and exhibited uncompetitive substrate inhibition (Figure 1). A single-exponential fit
to the single-turnover progress curve with 100 μM imipenem returned a turnover rate of 97 s-1 at 2 °C.

Figure 4 Stopped-flow UV−vis data (data points) collected at 300 nm for the reaction of 120 μM ImiS with 100
μM imipenem in 50 mM Tris buffer at pH 7.0 and 2 °C. The solid line is the simulated progress curve generated
by KINSIM when using the kinetic mechanism in Scheme 1 and the rate constants in Table 2.
Single-turnover (100 μM imipenem/meropenem and 120 μM ImiS) reactions were also probed with stoppedflow fluorescence studies, which monitor tryptophan fluorescence of the enzyme during catalysis. The resulting
stopped-flow fluorescence time courses were biphasic and showed a substantial quenching of fluorescence over
the first 10 ms of the reaction, followed by a relatively slow regain to baseline levels over the subsequent 45 ms
of the reaction. The stopped-flow fluorescence data were fitted with a double-exponential equation, which
yielded a rate of 160 ± 4 s-1 for the initial quenching phase and a rate of 98 ± 1 s-1 for the slower fluorescence
regain phase (Figure 5). Additional experiments were conducted at higher substrate and lower ImiS
concentrations. However, as with the stopped-flow UV−vis studies, the rates of fluorescence quench and regain
were lower at substrate concentrations > 200 μM.

Figure 5 Stopped-flow fluorescence data (data points) of 120 μM ImiS reacted with 100 μM imipenem in 50 mM
Tris at pH 7.0 and 2 °C. The data points show time dependence of the fluorescence emission at 320 nm after
excitation at 280 nm. The solid line is the simulated progress curve generated by KINSIM when using the kinetic
mechanism in Scheme 1 and the rate constants in Table 2.

Global Fittings and KINSIM Simulations.
Using previously reported kinetic mechanisms (17, 40, 48) and PC ProK global-fitting software, the stopped-flow
fluorescence data were fitted. The simple Michaelis−Menten mechanism was tested first, and more complicated
mechanisms were subsequently tested. The simplest mechanism that sufficiently fitted the data is shown in
Scheme 1; this mechanism was previously proposed for dinuclear ZnII-containing MβL L1 from S.
maltophilia when reacted with meropenem or cefaclor (48) (Table 2). Using the rate constants (Table 2), the
mechanism in Scheme 1, and KINSIM (35), we could suitably simulate the stopped-flow fluorescence and UV−vis
data (lines in Figures 4 and 5). The global fittings and kinetic simulations show that the rate constants
determined with single-turnover experiments are equal to k5 and k7. This scenario supports our analyses that the
second and third steps (k4 and k6, Scheme 1) of the mechanism are essentially irreversible.

Scheme 1
Table 2: Results of Global-Fitting Analysis of Stopped-Flow Fluorescence Data to Scheme 1a
parameter fitted rate
k1 (M-1 s-1) 1.0 × 108 ± 1.0 × 10-3

k2 (s-1)
1.0 × 104 ± 1.0 × 10-3
-1
k3 (s )
990 ± 1
-1
k4 (s )
2.4 × 10-4 ± 8.6 × 10-7
-1
k5 (s )
163 ± 1
-1
k6 (s )
4.0 × 10-3 ± 1.7 × 10-6
-1
k7 (s )
98 ± 1
a
Substrate used in the stopped-flow studies was imipenem. Data were fitted with Applied Photophysics PC ProK
global-fitting software using the mechanism in Scheme 1. The reported uncertainties represent standard errors
as determined by the ProK software (nonlinear Marquardt−Levenberg algorithm).
The values obtained from the global fittings (Table 2) were used to calculate steady-state parameters according
to kcat = (k3)(k5)(k7)/(k5)(k7) + (k3)(k7) + (k3)(k5) and KM = kcat{(k2 + k3)/(k1)(k3)}. The theoretical steady-state kinetic
constants are kcat = 58 s-1 and KM = 39 μM. The theoretical values of kcat and KM are within a factor of 3 of the
experimentally determined values at 2 °C: kcat = 130 ± 30 s-1 and KM = 90 ± 50 μM.

RFQ−EPR Studies.
The EPR spectrum of CoII-substituted ImiS is shown in Figure 6A and was simulated assuming a single
paramagnetic species with S = 3/2, MS = |±1/2〉, gx,y = 2.25, gz = 2.31, and E/D = 0.076 (Figure 4B). No other
CoII species were detected between 4 and 13 K, and at microwave powers up to 40 mW, an MS = |±3/2〉 signal
that was evident in some preparations of ImiS upon addition of substoichiometric CoII (12) was not observed in
the present work; this may be related to the higher pH employed (7.0 versus 6.5) and the known propensity of
CoII to adopt higher coordination numbers when possible (49). Upon the reaction of ImiS with imipenem for 10
ms, the spectrum (Figure 6C) had clearly changed and subtraction of the resting signal indicated the appearance
of a rhombic signal (Figure 7A) for which only the two low-field resonances could be resolved. From the EPR
spectrum after a 21 ms reaction time (Figure 6D), a second species (Figure 7B) could be clearly isolated by
subtraction of the resting signal and was simulated (Figure 7C) using S = 3/2, MS = |±1/2〉, gx,y = 2.24, gz =
2.18, E/D = 0.145, and Ay(59Co) = 40 G. It should be noted that, while the line shape was best-simulated including
an unresolved hyperfine coupling on the lowest field feature (gy for MS = |±1/2〉 of S = 3/2), the experimental
data only suggested three barely resolved hyperfine lines and the data were not of sufficient signal-to-noise to
confirm a full hyperfine pattern by the use of higher derivatives. The “21 ms” experimental spectrum (Figure 6D)
was well-modeled by the addition of the simulations of the resting signal, accounting for 94% of the spins, and
the rhombic signal, accounting for 6%. It is not clear whether the rhombic signal after 10 ms is the same as that
after 21 ms; while the two lower field resonances clearly coincide, the high-field gz resonance may be either
broadened or shifted in the “10 ms” spectrum compared to the “21 ms” spectrum, perhaps indicating some very
subtle structural differences. The EPR spectrum continued to change upon further reaction. The spectrum after
32 ms (Figure 6F) was again composed of the resting and rhombic signals (Figures 6G and 7D), and after 73 ms
(Figure 6E), the intensity of the rhombic signal was greater than that after 21 ms by a factor of about 1.6,
corresponding to 10% of the total CoII. When rapid-freeze-quenched samples were thawed and refrozen after 2
s, an EPR signal (Figure 6I) consisting of a 35% resting signal and 65% of a third distinct signal, the “product”
signal, was observed. The product signal was isolated (Figure 7F) by subtraction of the resting signal from Figure
6I and could be simulated (Figure 7G) assuming S = 3/2, MS = |±1/2〉, gx,y = 2.35, gz = 2.12, and E/D = 0.13. An
enzyme-bound product signal was also observed in RFQ−EPR spectra of B3 MβL L1 (21).

Figure 6 Trace A shows the resting EPR signal of CoII-substituted ImiS. Initial concentrations of ImiS and
imipenem were 1 and 5 mM, respectively. Traces C, D, F, H, and I show the EPR spectra of CoII-substituted ImiS
upon the reaction with imipenem for 10 ms at 2 °C (C), 21 ms at 2 °C (D), 32 ms at 2 °C (F), 73 ms at 2 °C (H), and
2 s at 2 °C (I). Trace B is a computer simulation of trace A, assuming S = 3/2, MS = |±1/2〉, gx,y = 2.25, gz = 2.31,
and E/D = 0.076. Traces E, G, and J are models for D, F, and I, respectively, and consist of (0.94 × A) + (0.06 ×
trace C of Figure 7) (E), (0.89 × A) + (0.11 × trace C of Figure 7) (F), and (0.45 × A) + (0.65 × trace C of Figure 7) (I).
Experimental EPR spectra were recorded at 12 K with 1 mW microwave power at 9.63 GHz. A 10 G (1 mT) field
modulation at 100 kHz was employed.

Figure 7 Isolated species. Traces A, B, D, E, and F are the EPR difference spectra generated by subtraction of the
resting signal (trace A of Figure 6) from those of ImiS upon the reaction with imipenem at 2 °C for 10 ms, 21 ms,
32 ms, 73 ms, and 2 s, respectively. Traces C and G are the computer simulations of traces B and F,
assuming S = 3/2, MS = |±1/2〉, gx,y = 2.24, gz = 2.18, E/D = 0.145, and Ay(59Co) = 40 G and S = 3/2, MS = |±1/2〉
, gx,y = 2.35, gz = 2.12, and E/D = 0.13.

Discussion
There have been many reports on the reaction mechanisms of dinuclear ZnII-containing MβLs (from subgroups
B1 and B3). In studies using CcrA and L1 and nitrocefin as the substrate, a ring-opened, nitrogen anionic
intermediate was identified and kinetic studies revealed that the protonation of this intermediate was ratelimiting (17−20, 41). RFQ−EPR studies demonstrated that this intermediate yielded a novel EPR signal (21). A
similar intermediate has not been observed in studies with Bacillus cereus β-lactamase II (50). Spencer and coworkers later extended mechanistic studies on L1 using other substrates such as cefaclor and meropenem (48).
Kinetic analyses revealed that β-lactam bond cleavage is rate-limiting with these substrates, and these authors
hypothesized that the intermediate observed when nitrocefin is used as a substrate is unique to nitrocefin and
due to the highly conjugated, bis-nitro-substituted styryl substituent (48). Therefore, the reaction mechanisms
of the B1 and B3 MβLs are becoming clearer. In contrast, there is little mechanistic information [except that
inferred by a recent crystal structure on CphA (11) and that proposed on the basis of very recent computational
studies on CphA (51, 52)] on any of the mononuclear ZnII-containing B2 MβLs.
Many enzymes, including L1 (27), exhibit substrate inhibition at high substrate concentrations (29); however, the
concentrations of substrate required to inhibit ImiS are relatively low (>200 μM). Analysis of the steady-state
kinetic data demonstrates that the observed substrate inhibition in ImiS is uncompetitive (Figure 1), which
indicates that the inhibitory substrate molecule binds to the ES (or species derived from the ES) complex. With

ImiS, it is possible that the substrate could bind with the β-lactam carbonyl or the β-lactam nitrogen coordinated
to the metal ion, with one binding mode being the catalytically active mode and one mode describing an
inhibited enzyme. The scenario would be expected to result in competitive substrate inhibition. It has been
proposed for the B1 and B3 MβLs that there is a loop that extends over the active site that may play a role in
catalysis by “clamping down” and activating the substrate during catalysis (42, 53, 54). In the case of CphA (and
presumably ImiS), there is an α helix (α3) that is located where this loop is in other enzymes (11). It is possible
that a second molecule of the substrate could bind to ES and prevent this α helix from “clamping down” on the
substrate. Further studies are required to better understand substrate inhibition in ImiS.
Our first efforts to probe the mechanism used pH dependence and solvent isotope studies. As previously
reported for L1 and CcrA (18, 28, 41), there are no apparent inflection points in the pH dependence plots. With
L1 and CcrA, it was argued that the pKa of the bridging solvent group was much lower than 5, as a result of
bridging two divalent ZnII ions. On the basis of extensive literature precedents on ZnII hydrolases (55−60), it is
possible that the ZnII in ImiS in conjunction with Asp120 could generate a hydroxide that has a pKa < 5. However,
recent computational studies (52), along with predictions from the crystallographic studies (11), suggest that the
nucleophile in CphA is not generated by ZnII and that the nucleophile is generated by assistance of His118 and
Asp120 (11) or solely by Asp120 (52). In addition, our RFQ−EPR studies suggest that there are only five ligands
bound to the metal during catalysis, and these ligands are most likely three amino acid residues (Asp120,
Cys221, and His263) and two points of attachment from the substrate (see below) (11). If in fact the reactive
nucleophile is generated without the direct coordination to the metal ion, we hypothesize that both Asp120 and
His118 participate in the generation of this nucleophile and that the pKa of this solvent molecule is atypically
low.
ImiS exhibited a solvent isotope effect that was very similar to that of dinuclear ZnII-containing L1 and CcrA (28,
41); however, it is possible that there are >1 rate-significant protons in flight for ImiS. These data demonstrate
that there is a rate-significant proton transfer in the reaction catalyzed by ImiS (30). Given that the rate-limiting
step is most likely C−N bond cleavage (see below), one potentially important proton transfer could be to the ring
nitrogen in the product. It is also possible that a proton transfer from the solvent molecule to generate the
putative nucleophile could explain why multiple, rate-limiting proton transfers are possible with ImiS.
The roles of Lys224 and Asn233 were probed using site-directed mutagenesis. Several groups have
demonstrated that Lys224 is involved in substrate binding to several of the dinuclear-ZnII-containing MβLs
(28, 42, 43, 61−64. In fact, the recent structure of CphA bound to product suggests that Lys224 interacts with the
3‘ carboxylate on the substrate (11), and computational studies support a role of Lys224 in substrate binding
(51). In contrast, our studies on the K224T mutant indicate that Lys224 is involved with catalysis, suggesting that
the orientation of the 3‘ carboxylate is catalytically important. Crystallographic and computational studies
suggested a role of the backbone amide of Asn233 in forming a hydrogen bond with the 3‘ carboxylate on the
substrate (11, 51), and computational studies additionally suggested that the side-chain amide of Asn233
hydrogen bonds with the β-lactam carbonyl on the substrate (52). Our mutagenesis studies demonstrate that
the side chain of Asn233 is not involved in substrate binding or catalysis, which supports the former prediction
but not the latter.
Stopped-flow fluorescence and UV−vis studies were used next to probe the mechanism of ImiS. Stopped-flow
fluorescence traces were similar in appearance to those of L1 (32, 48). The fluorescence properties of L1 are due
to a single Trp (Trp37), which is located in close proximity to the dinuclear ZnII site (22). It is likely that the
fluorescence changes upon substrate binding to ImiS are also due to a single tryptophan, possibly Trp87, which
lies near the putative substrate-binding site and within 10 Å of ZnII in CphA (11). Stopped-flow fluorescence
studies of 120 μM ImiS with 100 μM imipenem (or meropenem) resulted in a rapid decrease in fluorescence
(kobs = 160 s-1) and a relatively slow regain in fluorescence (kobs = 98 s-1). Stopped-flow UV−vis studies, which

monitored the hydrolysis of the β-lactam bond in the substrate (48), showed a rapid decrease in absorbance
that was best-fitted with a single-exponential equation yielding a kobs = 97 s-1. As previously suggested for L1
(48), the regain of fluorescence because of substrate loss and the loss of absorbance are due to β-lactam
hydrolysis in ImiS, and this step is probably the rate-determining step.
In an effort to offer a minimal kinetic mechanism that describes the data, global analyses and KINSIM were used
to test several different kinetic mechanisms. The single-turnover data of ImiS were best-fitted/simulated using
the kinetic mechanism and rate constants shown in Scheme 1 and Table 2, respectively. The minimal kinetic
mechanism of ImiS shown in Scheme 1 is very similar to that of L1 (48) and suggests that the rate-limiting step is
β-lactam hydrolysis. This mechanism also suggests the existence of a second ES complex (ES* in Scheme 1). The
absence of ES* in our global analyses and KINSIM fits resulted in poor fits of the data.
EPR spectroscopy of ImiS upon the reaction with imipenem identified two new imipenem-dependent signals
because of isolated CoII. One, the rhombic signal, is indicative of a highly distorted geometry and suggestive of 5fold coordination of CoII. The partial resolution of 59Co hyperfine coupling of 40 G (4.3 × 10-3 cm-1) indicates a
narrow intrinsic EPR line and is entirely consistent with such a structure, in which the rigid ligand environment
necessary to constrain the distorted structure precludes large strains in g and/or the zero-field splitting
parameters. From a structural basis, therefore, it is likely that the rhombic signal corresponds to either ES* or EI
in the reaction proposed in Figure 8. In principle, the kinetic studies should provide further information as to
which intermediate likely accumulates in sufficient amounts to be observed by EPR. In the case of ImiS,
however, the situation is complicated by the substrate inhibition observed with imipenem. In the EPR
experiment, the initial substrate concentration in the reaction mixture (after mixing) was 2.5 mM, and by
extrapolation of Figure 1, the overall reaction rate may be expected to be of the order of 10% of that of the
optimum rate. Uncompetitive inhibition, which best fits the data for ImiS and imipenem (Figure 1), implies
further binding of imipenem to either ES, ES*, or EI, rather than a second, nonproductive mode of binding to the
hitherto uncomplexed enzyme. Because the inhibition is not competitive, any molecule of imipenem to interact
with the active site of ImiS will rapidly form ES and the imipenem pool will be initially depleted according
to k1 and k2 and more slowly as fewer naked ImiS molecules are available. Because the enzyme and substrate are
mixed in a 1:1 ratio and because k1 is high and Ki > Km, substrate inhibition will only be a factor during the mixing
time, when local relative concentrations of imipenem may be higher than the eqiulibrium concentration. The
mixing time is estimated to be ∼1 ms. This is comparable with the optimum rate of formation of ES*, and thus,
the rate of formation of ES* from ES is unlikely to be impeded by more than a factor of 2 or so if this is indeed
the step inhibited by excess substrate. Thus, ES* formation is likely to be complete between 1 and 2 ms after
mixing. The formation of EI is expected after a further 7 ms, i.e., after 8−9 ms, and the rhombic species observed
after 10 ms is, therefore, assignable to the EI complex. While the simplest interpretation of the EPR spectra
beyond 10 ms invoked a single species (the rhombic) in addition to the resting species, the kinetics suggest an
alternative explanation, that gz of the rhombic species is indeed unresolved, as in the signal isolated by the
difference from the 10 ms reacted sample, and that the appearance of a resolved high-field feature in spectra
recorded at longer reaction times is due to a contribution from the product species. While the EPR data are not
of sufficient quality to differentiate these two explanations, the latter is entirely consistent with the kinetics,
because the product complex would be expected to begin accumulating at around 18−19 ms. Thus, it is
proposed that the rhombic species represents EI and the product species represents EP.

Figure 8 Proposed reaction mechanism for ImiS.
These data and previous crystallographic data (11) allow us to propose a reaction mechanism for ImiS (Figure 8).
In the first step, the substrate binds to the active site replacing a water molecule. Initially, the carboxylate on the
substrate interacts with Lys224 and ZnII; however, on the basis of kinetic simulations, we believe that a second
ES complex (labeled ES*) forms. We postulate that the ZnII−substrate nitrogen interaction forms in ES*,
generating a five-coordinate metal center. In our proposed mechanism, the nucleophile is generated by Asp120
and His118 as previously proposed (11); this nucleophile attacks the β-lactam carbonyl, possibly activated by
His196 (11), to generate a tetrahedral intermediate, which we have labeled EI. It is important to note that the
recent computational study suggested that a tetrahedral intermediate does not form in the proposed
mechanism of CphA (52), and our data cannot support nor refute this hypothesis. It is entirely possible that EI is
in fact a ring-opened, unprotonated species, similar to that reported in studies with CcrA and L1 when reacted
with nitrocefin (17, 19, 21). In either case, a proton must be transferred to the ring-opened nitrogen to generate
the product. We have also included the structure of the EP complex in the mechanism because this species was
detected by RFQ−EPR studies. The inclusion of an EP complex in our kinetic simulations did not affect the fits as
long as the rate of formation of EP is much faster than the breakdown of EI. Our spectroscopic data do not
support the previous hypothesis (52) of Asp120 releasing from the metal ion during catalysis, yielding a fourcoordinate intermediate.
The recent crystal structure of CphA showed the presence of a bicyclic product of biapenem in the active site of
the enzyme (11). The authors proposed that, after β-lactam bond cleavage, a substantial bond rotation occurs
that allows for the proton on the hydroxyethyl substituent found on all carbapenems to transfer to the 2‘
position on the five-membered ring of the substrate and for the nucleophilic attack of the oxygen at the 3
position. Because of steric constraints, it is clear that this cyclization occurs after C−N bond cleavage. Our
product inhibition data strongly suggest that the bicyclic product is kinetically competent and is the final product
of the reaction catalyzed by ImiS.

The results described herein demonstrate that MβLs from each of the distinct subclasses share a common ratedetermining step, which is C−N bond cleavage. This fact suggests that inhibitors designed on this step will inhibit
all MβLs, regardless of whether the enzymes are mono- or dinuclear ZnII-containing enzymes.
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